64

Great Tree Pharmacy Co Ltd

6469 · TWO · Healthcare / Pharmaceutical Retailers

60.90TWD+4.10 (+7.22%)

Price History

Full chart

Market Stats

Previous Close56.80
Open57.90
Day Range57.40 – 60.90
52-Week Range63.70 – 118.64
Volume512.57K
Market Cap10.26B
P/E (TTM)20.61
Forward P/E0.00
EPS3.13
Dividend Yield4.90%
Beta0.07
50-Day Avg68.56
200-Day Avg78.70

About

Great Tree Pharmacy Co., Ltd. engages in medicines, health food, maternal and infant products, and cosmetics businesses in Taiwan, Mainland China, and Malaysia. It provides drug procurement services, as well as acts as an agent for various clinics, joint clinics, and community health centers. The company is also involved in selling food and beverages, and daily necessities; cleaning supplies; wholesale and retail of cosmetics, and other goods; cargo sorting, packaging, and warehousing; retail sale of animal medicines and ornamental animals; fish and pet food retail; medical equipment and pet-related products; wholesale of precision instruments; development and retail business; biotechnology; investment business, and specific specialized zones businesses. In addition, it provides technical services; management consultants, residential and building properties; development, leasing, rental, and sales of real estate; property leasing; industrial plant development; biotechnology research and development; and other wholesale and retail business. The company was formerly known as Tianjin Pharmaceutical Co., Ltd. and changed its products to Great Tree Pharmacy Co., Ltd. The company was incorporated in 2001 and is based in Taoyuan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMs. Shu-Yi Wu
  • Employees0
  • HeadquartersNo. 186, Fuxing Road, Taoyuan City, Taiwan, 330046, Taiwan
  • Websitehttps://www.greattree.com.tw

Leadership

  • Ms. Shu-Yi WuAccounting Supervisor & Assistant Manager of Finance Dept and Supervisor of Corporate Governance
  • Mei-Yun LiuAssistant Manager of the Administration Department
  • Ms. Shu-Yi HuangChief Auditor

Financials

Income Statement

Currency: TWD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue911.06M1.14B1.66B2.16B2.80B3.62B4.90B6.60B8.64B11.28B14.56B16.14B17.27B18.90B
Growth (%)-+24.71%+46.32%+29.92%+29.73%+29.33%+35.24%+34.71%+30.90%+30.55%+29.11%+10.84%+7.00%+9.39%
Cost of Revenue704.52M812.00M1.18B1.62B2.12B2.70B3.69B5.01B6.46B8.34B10.55B11.66B12.43B13.48B
Gross Profit206.54M324.19M477.57M537.87M678.24M920.00M1.21B1.60B2.18B2.94B4.01B4.49B4.84B5.42B
Gross Margin22.67%28.53%28.73%24.90%24.21%25.39%24.60%24.17%25.28%26.09%27.54%27.79%28.03%28.67%
Operating Expense173.87M241.07M359.97M438.98M564.62M795.94M1.07B1.40B1.91B2.40B3.08B3.59B4.04B4.73B
Operating Income32.67M83.11M117.60M98.89M113.62M124.06M138.33M198.40M276.28M544.72M927.99M899.32M801.43M689.33M
Operating Margin3.59%7.32%7.07%4.58%4.05%3.42%2.82%3.01%3.20%4.83%6.37%5.57%4.64%3.65%
EBITDA42.00M96.14M138.80M126.95M149.25M171.62M205.96M528.04M703.26M1.04B1.54B1.60B1.71B1.71B
EBITDA Margin4.61%8.46%8.35%5.88%5.33%4.74%4.20%8.00%8.14%9.25%10.54%9.91%9.88%9.06%
Net Income33.79M68.10M95.85M77.47M92.86M102.42M106.00M135.99M194.31M407.42M700.07M666.05M680.77M600.42M
Net Income Margin3.71%5.99%5.77%3.59%3.31%2.83%2.16%2.06%2.25%3.61%4.81%4.13%3.94%3.18%
Interest Expense-13.00K11.00K--217.00K3.41M26.94M32.87M35.13M45.85M57.50M58.90M85.83M
Interest Expense % of Total Revenue-0.00%0.00%--0.01%0.07%0.41%0.38%0.31%0.31%0.36%0.34%0.45%

Balance Sheet

Currency: TWD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets303.03M444.41M779.34M868.89M1.28B1.54B2.31B4.68B6.01B7.39B10.12B10.77B12.13B13.76B
Total Liabilities117.83M164.52M295.68M327.54M543.48M730.46M1.23B3.46B4.49B5.44B7.49B7.42B8.48B9.76B
Total Equity185.19M279.89M483.65M541.35M736.42M804.71M1.05B1.20B1.50B1.93B2.60B3.28B3.60B3.92B
Cash74.71M102.32M123.33M131.46M194.88M274.67M633.66M308.12M835.80M1.31B2.46B2.13B1.90B1.77B
Total Debt30.00M34.79M88.73M103.59M233.08M319.98M655.07M2.56B3.33B3.83B5.28B5.14B--
Net Debt-44.72M-67.53M-34.60M-27.87M38.20M45.31M21.41M2.25B2.49B2.52B2.83B3.00B-683.60M

Cash Flow

Currency: TWD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow36.85M54.53M94.56M-3.16M129.15M156.85M131.33M224.89M728.13M1.08B1.23B890.33M1.14B1.17B
Investing Cash Flow------115.74M-156.52M-291.20M-253.47M-268.43M-465.58M---
Financing Cash Flow15.02M30.11M103.90M-20.67M100.68M38.68M384.18M-259.22M53.02M-336.57M389.10M-795.84M--
Capital Expenditure16.82M33.92M57.93M92.42M91.83M120.35M182.39M278.39M251.17M254.48M315.76M326.30M392.08M378.78M
Free Cash Flow20.04M20.60M36.63M-95.58M37.32M36.51M-51.06M-53.50M476.96M823.18M910.93M564.03M746.59M787.01M
Dividends Paid18.90M18.00M42.00M21.00M50.52M34.48M54.90M47.52M43.48M53.47M182.24M422.52M405.51M436.72M
FCF to OCF54.37%37.78%38.74%3028.45%28.90%23.27%-38.88%-23.79%65.50%76.39%74.26%63.35%65.57%67.51%
Dividend Paid to FCF94.32%87.37%114.66%-21.97%135.37%94.45%-107.52%-88.81%9.12%6.50%20.01%74.91%54.32%55.49%

Earnings

Report DateSep 30, 2015Mar 2, 2016May 16, 2016Aug 13, 2016Nov 30, 2016Feb 13, 2017May 12, 2017Aug 14, 2017Nov 14, 2017Mar 27, 2018May 16, 2018Aug 14, 2018Nov 14, 2018Feb 27, 2019Apr 2, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Feb 23, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Feb 23, 2023May 12, 2023Aug 10, 2023Nov 10, 2023Feb 27, 2024May 14, 2024Aug 8, 2024Nov 7, 2024Feb 26, 2025May 9, 2025Aug 13, 2025Nov 10, 2025Feb 26, 2026May 8, 2026
EPS Estimate--0.160.12----0.49------------------1.030.761.050.951.241.261.621.161.111.251.261.321.241.161.261.29
EPS Actual0.230.410.180.150.290.360.230.290.500.440.300.270.330.350.270.350.350.310.440.420.420.540.651.050.941.221.281.551.081.041.011.031.031.601.041.051.041.081.180.990.810.940.00
Surprise--12.50%25.00%----2.04%------------------50.49%42.11%-0.95%6.32%-16.94%-18.25%-1.23%-10.34%-5.41%-16.80%-14.29%-10.61%-20.16%-30.17%-25.40%-100.00%
Timing--Pre-marketPre-market-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-------------Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap10.26B
Enterprise Value14.97B
Trailing P/E20.61
Forward P/E0.00
Price / Sales0.54
Price / Book2.80
EPS3.13
Book Value24.45
Revenue (TTM)19.02B
Gross Profit (TTM)5.43B
EBITDA785.17M
Profit Margin2.71%
Operating Margin1.98%
Return on Equity13.46%
Return on Assets2.40%
Shares Outstanding159.05M
Shares Float78.02M
Beta0.07
Dividend Yield4.90%
Dividend Rate3.16
Payout Ratio1.80%

Dividends

20261×
3.16Aug 4, 2026
20251×
2.75Jul 1, 2025
20241×
2.57Jul 9, 2024
20231×
2.73Jul 5, 2023
20221×
1.19Jun 29, 2022
20211×
0.35Jul 22, 2021
20201×
0.30Jul 16, 2020
20191×
0.30Jul 24, 2019
20181×
0.37Sep 6, 2018
20171×
0.23Aug 31, 2017
20161×
0.34Jul 19, 2016
20151×
0.15Jul 9, 2015

Stock Splits

  • Aug 4, 20261059.9552:1000
  • Aug 22, 20251129.8661:1000
  • Aug 12, 20241169.8677:1000
  • Aug 11, 20231228.0846:1000
  • Aug 2, 20221257:1000
  • Aug 30, 20211297.053:1000
  • Sep 9, 20201176.284:1000
  • Jul 16, 20201180:1000
  • Aug 26, 20191129.146:1000
  • Sep 6, 20181091.045:1000
  • Aug 31, 20171150:1000
  • Aug 30, 20161050:1000
  • Aug 31, 20151100:1000